T1	outcome 582 590	CIA rate
T2	iv-bin-percent 595 600	90.2%
T3	iv-bin-percent 613 618	73.5%
T4	cv-bin-percent 646 651	72.1%
T5	outcome 661 670	at 1 year
T6	iv-bin-percent 688 693	66.7%
T7	iv-bin-percent 695 700	73.3%
T8	cv-bin-percent 706 711	58.9%
T9	outcome 727 737	at 3 years
T10	total-participants 290 293	122
T11	eligibility 294 320	premenopausal EBC patients
T12	intervention-participants 441 443	34
T13	control-participants 505 508	129
T14	intervention 69 93	anthracycline and taxane
T15	outcome 910 965	Serum estradiol and follicle-stimulating hormone levels
T16	control 406 439	doxorubicin/cyclophosphamide (AC)
